Mission Moment – Research Fast Facts

What: As there are few means of preventing or early screening for most blood cancers, the LLS research

agenda is focused on finding cures. LLS drives research in areas of unmet medical need, and helps to bridge

the gap between academic discovery and drug development. LLS identifies and funds the most promising

blood cancer research projects around the world, and forges partnerships with academic institutions,

biotechnology and pharmaceutical companies to accelerate the development of new therapies.

Why: LLS’s investment in research has played a critical role in advancing many of today’s life-saving

therapies for blood cancer patients.

 Since LLS first started investing in research more than 60 years ago, cures for many patients with acute

lymphocytic leukemia (ALL) and Hodgkin lymphoma have been achieved.

 Survival rates for many blood cancer patients have doubled, tripled and even quadrupled since 1960.

 From 2001 through 2013, nearly 40% of new anti-cancer treatments were FDA-approved for blood cancer

patients, more first approvals than for any other group of cancer patients.

 LLS research grants have funded many important advances, including targeted and immunotherapies. Some

therapies LLS helped advance include imatinib, bortezomib, lenalidomide, rituximab and ibrutinib.

P.S. Don’t forget to donate to the cause: http://pages.teamintraining.org/gba/nikesf14/ashbo

❤ Ash


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s